Identification of Synergistic Drug Combinations to Target KRAS-Driven Chemoradioresistant Cancers Utilizing Tumoroid Models of Colorectal Adenocarcinoma and Recurrent Glioblastoma

Treatment resistance is observed in all advanced cancers. Colorectal cancer (CRC) presenting as colorectal adenocarcinoma (COAD) is the second leading cause of cancer deaths worldwide. Multimodality treatment includes surgery, chemotherapy, and targeted therapies with selective utilization of immuno...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Kshama Gupta, Jeremy C. Jones, Virginea De Araujo Farias, Yuri Mackeyev, Pankaj K. Singh, Alfredo Quiñones-Hinojosa, Sunil Krishnan
Materialtyp: Artigo
Språk:Inglês
Publicerad: Frontiers Media S.A. 2022-05-01
Serie:Frontiers in Oncology
Ämnen:
KRAS
DDR1
BCR-ABL1
COAD
GBM
chemoradioresistance
Länkar:https://www.frontiersin.org/articles/10.3389/fonc.2022.840241/full
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk